Eli Lilly and Co

詳細情報 Eli Lilly and Co 企業名

Eli Lilly and Company is a medicine company. The Company discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes, obesity and other cardiometabolic products include Basaglar, Humalog, Mounjaro, Trulicity and Zepbound. Its oncology products include Alimta, Retevmo, Tyvyt and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh and Taltz. Its neuroscience products include Cymbalta and Emgality. Its other products and therapies include Cialis and Forteo. It manufactures and distributes its products through facilities in the United States (U.S.), including Puerto Rico, and in Europe and Asia. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing, as well as clinical and pre-clinical radioligand therapies. It is also developing oral small molecule inhibitor of α4β7 integrin (known as MORF-057) for inflammatory bowel disease (IBD).

企業情報

企業コードLLY

会社名Eli Lilly and Co

上場日Jul 09, 1970

最高経営責任者「CEO」Mr. David A. (Dave) Ricks

従業員数47000

証券種類Ordinary Share

決算期末Jul 09

本社所在地Lilly Corporate Ctr

都市INDIANAPOLIS

証券取引所NYSE Consolidated

国United States of America

郵便番号46285

電話番号13172762000

ウェブサイトhttps://www.lilly.com/

企業コードLLY

上場日Jul 09, 1970

最高経営責任者「CEO」Mr. David A. (Dave) Ricks

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Anne E. White

Executive Vice President, President - Lilly Neuroscience

74.21K

+13.18%

Mr. J. Erik Fyrwald

Independent Director

72.75K

+0.02%

Mr. Patrik Jonsson

Executive Vice President, President of Lilly Cardiometabolic Health and President, Lilly USA

54.13K

+20.12%

Mr. Edgardo Hernandez

Executive Vice President, President - Manufacturing Operations

39.75K

+4.13%

Mr. Ilya Yuffa

Executive Vice President, President of Lilly International

27.51K

-4.35%

Ms. Anat Hakim

Executive Vice President, General Counsel, Secretary

25.66K

-41.06%

Dr. Katherine Baicker, Ph.D.

Independent Director

23.16K

+0.62%

Mr. Diogo Rau

Executive Vice President, Chief Information and Digital Officer

19.72K

+77.63%

Mr. Lucas E. Montarce

Chief Financial Officer, Executive Vice President

13.97K

+26.18%

Mr. Eric Dozier

Executive Vice President - Human Resources and Diversity

9.84K

+15.72%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Anne E. White

Executive Vice President, President - Lilly Neuroscience

74.21K

+13.18%

Mr. J. Erik Fyrwald

Independent Director

72.75K

+0.02%

Mr. Patrik Jonsson

Executive Vice President, President of Lilly Cardiometabolic Health and President, Lilly USA

54.13K

+20.12%

Mr. Edgardo Hernandez

Executive Vice President, President - Manufacturing Operations

39.75K

+4.13%

Mr. Ilya Yuffa

Executive Vice President, President of Lilly International

27.51K

-4.35%

Ms. Anat Hakim

Executive Vice President, General Counsel, Secretary

25.66K

-41.06%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Diabetes-Mounjaro

3.84B

30.18%

Diabetes-Zepbound

2.31B

18.16%

Oncology-Verzenio

1.16B

9.10%

Diabetes-Trulicity

1.10B

8.60%

Diabetes-Jardiance

1.01B

7.97%

Other

3.31B

25.98%

地域別USD

会社名

収益

比率

U.S.

8.49B

66.70%

Europe

2.39B

18.77%

Other foreign countries

997.40M

7.84%

China

450.80M

3.54%

Japan

402.20M

3.16%

事業別

地域別

事業別USD

会社名

収益

比率

Diabetes-Mounjaro

3.84B

30.18%

Diabetes-Zepbound

2.31B

18.16%

Oncology-Verzenio

1.16B

9.10%

Diabetes-Trulicity

1.10B

8.60%

Diabetes-Jardiance

1.01B

7.97%

Other

3.31B

25.98%

株主

更新時刻: Fri, May 16

株主統計

種類

株主統計

比率

Lilly Endowment, Inc.

10.12%

The Vanguard Group, Inc.

8.46%

PNC Investments LLC

5.40%

BlackRock Institutional Trust Company, N.A.

4.38%

State Street Global Advisors (US)

3.64%

Other

68.01%

株主統計

比率

Lilly Endowment, Inc.

10.12%

The Vanguard Group, Inc.

8.46%

PNC Investments LLC

5.40%

BlackRock Institutional Trust Company, N.A.

4.38%

State Street Global Advisors (US)

3.64%

Other

68.01%

種類

株主統計

比率

Investment Advisor

46.21%

Investment Advisor/Hedge Fund

18.49%

Foundation

10.10%

Research Firm

1.94%

Pension Fund

1.83%

Bank and Trust

1.80%

Insurance Company

1.48%

Sovereign Wealth Fund

1.24%

Hedge Fund

0.91%

Other

16.00%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

5717

798.76M

84.28%

+2.87M

2025Q1

5710

800.38M

84.44%

+5.04M

2024Q4

5528

795.43M

83.87%

+627.51K

2024Q3

5177

793.57M

83.49%

-5.03M

2024Q2

5068

795.80M

83.72%

-2.01M

2024Q1

4916

795.04M

83.62%

-6.22M

2023Q4

4670

799.46M

84.21%

-2.37M

2023Q3

4354

800.21M

84.30%

-1.19M

2023Q2

4197

799.48M

84.22%

-4.32M

2023Q1

4061

801.36M

84.15%

-9.39M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Lilly Endowment, Inc.

96.02M

10.13%

-220.00K

-0.23%

Mar 31, 2025

The Vanguard Group, Inc.

78.87M

8.32%

+4.97M

+6.73%

Mar 31, 2025

PNC Investments LLC

51.09M

5.39%

+1.95K

+0.00%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

41.47M

4.38%

+359.58K

+0.87%

Mar 31, 2025

State Street Global Advisors (US)

34.44M

3.63%

+124.04K

+0.36%

Mar 31, 2025

Fidelity Management & Research Company LLC

27.18M

2.87%

-2.17M

-7.40%

Mar 31, 2025

Capital World Investors

18.38M

1.94%

-1.17M

-5.98%

Mar 31, 2025

Geode Capital Management, L.L.C.

18.53M

1.95%

+1.14M

+6.58%

Mar 31, 2025

T. Rowe Price Associates, Inc.

17.98M

1.9%

-1.75M

-8.89%

Mar 31, 2025

Capital Research Global Investors

15.75M

1.66%

+4.99M

+46.39%

Mar 31, 2025

詳細を見る

関連ETF

更新時刻: Wed, Aug 6

銘柄名

比率

Defiance Daily Target 2X Long LLY ETF

84.88%

iShares U.S. Pharmaceuticals ETF

20.57%

Harbor Health Care ETF

16.13%

Roundhill GLP-1 & Weight Loss ETF

15.57%

VanEck Pharmaceutical ETF

13.65%

Amplify Weight Loss Drug & Treatment ETF

12.82%

Proshares Ultra Health Care

12.54%

Health Care Select Sector SPDR Fund

12.53%

iShares U.S. Healthcare ETF

12.33%

Fidelity MSCI Health Care Index ETF

11.06%

詳細を見る

Defiance Daily Target 2X Long LLY ETF

比率84.88%

iShares U.S. Pharmaceuticals ETF

比率20.57%

Harbor Health Care ETF

比率16.13%

Roundhill GLP-1 & Weight Loss ETF

比率15.57%

VanEck Pharmaceutical ETF

比率13.65%

Amplify Weight Loss Drug & Treatment ETF

比率12.82%

Proshares Ultra Health Care

比率12.54%

Health Care Select Sector SPDR Fund

比率12.53%

iShares U.S. Healthcare ETF

比率12.33%

Fidelity MSCI Health Care Index ETF

比率11.06%

配当金

過去5年間の配当金総支払額は 18.06B 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Dec 09, 2024

LLY.NB Interim Cash Dividend of gross USD 1.5 paid on Mar 10, 2025 going ex on Feb 14, 2025

Feb 14, 2025

Mar 10, 2025

Feb 14, 2025

Oct 28, 2024

LLY.NB Final Cash Dividend of gross USD 1.3 paid on Dec 10, 2024 going ex on Nov 15, 2024

Nov 15, 2024

Dec 10, 2024

Nov 15, 2024

Jun 24, 2024

LLY.NB Interim Cash Dividend of gross USD 1.3 paid on Sep 10, 2024 going ex on Aug 15, 2024

Aug 15, 2024

Sep 10, 2024

Aug 15, 2024

May 06, 2024

LLY.NB Interim Cash Dividend of gross USD 1.3 paid on Jun 10, 2024 going ex on May 15, 2024

May 16, 2024

Jun 10, 2024

May 15, 2024

Dec 08, 2023

LLY.NB Interim Cash Dividend of gross USD 1.3 paid on Mar 08, 2024 going ex on Feb 14, 2024

Feb 15, 2024

Mar 08, 2024

Feb 14, 2024

Nov 01, 2023

LLY.NB Final Cash Dividend of gross USD 1.13 paid on Dec 08, 2023 going ex on Nov 14, 2023

Nov 15, 2023

Dec 08, 2023

Nov 14, 2023

Jun 26, 2023

LLY.NB Interim Cash Dividend of gross USD 1.13 paid on Sep 08, 2023 going ex on Aug 14, 2023

Aug 15, 2023

Sep 08, 2023

Aug 14, 2023

May 01, 2023

LLY.NB Interim Cash Dividend of gross USD 1.13 paid on Jun 09, 2023 going ex on May 12, 2023

May 15, 2023

Jun 09, 2023

May 12, 2023

Dec 12, 2022

LLY.NB Interim Cash Dividend of gross USD 1.13 paid on Mar 10, 2023 going ex on Feb 14, 2023

Feb 15, 2023

Mar 10, 2023

Feb 14, 2023

Oct 17, 2022

LLY.NB Final Cash Dividend of gross USD 0.98 paid on Dec 09, 2022 going ex on Nov 14, 2022

Nov 15, 2022

Dec 09, 2022

Nov 14, 2022

詳細を見る

株式分割

日付

種類

比率

データなし

日付

種類

比率

データなし

639.440USD

Eli Lilly and Co

639.440

概要

企業名

金融